Ekso Bionics Holdings, Inc. (EKSO)
12.29
+0.85
(+7.43%)
USD |
NASDAQ |
Apr 30, 16:00
12.29
0.00 (0.00%)
After-Hours: 17:17
Ekso Bionics Holdings Cash from Operations (TTM) : -11.96M for March 31, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Integra LifeSciences Holdings Corp. | 50.38M |
| Abbott Laboratories | -- |
| Accuray, Inc. | 4.547M |
| Alphatec Holdings, Inc. | 45.23M |
| Plus Therapeutics, Inc. | -20.78M |